System Alert

Due to planned maintenance, the EHBs will be unavailable on Friday (06/05/2020 8:00PM) until Sunday (06/07/2020 6:00PM). Please ensure that you save your work and log off prior to the start of these activities to prevent unintentional loss of data.

Skip to Main Content

HRSA Electronic Handbooks

Funding Cycle View


Building Capacity to Implement Rapid Antiretroviral Therapy (ART) Start for Improved Care Engagement in the Ryan White HIV/AIDS Program – Implementation Sites

  • Program Name:Special Projects of National Significance
  • Activity Code:H97
  • Application Available:4/15/2020
  • Application Deadline:6/15/2020
  • Created By:Wildberger, William
  • Created On:1/31/2020
  • Last Updated by:Wildberger, William
  • Last Updated On:5/15/2020
  • Estimated Project Start Date:9/1/2020

 Details of the changes posted in this announcement

Modification published on 05/15/2020
MODIFICATION: MAY 15, 2020 – total annual funding increased from $2,000,000 to $3,075,000; award ceiling amount increased from $200,000 to $205,000; number of implementation sites increased from 10 to 15.


 Announcement Information

Announcement Number HRSA-20-114
Announcement Code
CFDA Number 93.928
Provisional No
Activity Code H97
Competitive Yes
Fiscal Year 2020


This notice announces the opportunity to apply for funding under the Building Capacity to Implement Rapid Antiretroviral Therapy (ART) Start to Improve Care Engagement in the Ryan White HIV/AIDS Program – Implementation Sites. In support of the Ending the HIV Epidemic (EHE): A Plan for America Initiative, the purpose of this program is to fund up to 10 organizations interested in the implementation and evaluation of “rapid start” or the accelerated entry into HIV medical care and rapid initiation of antiretroviral therapy (ART) for low income and underserved people with HIV who are newly diagnosed, new to care, or out of care, especially racial and ethnic minorities. This program will fund organizations that have the capacity (e.g., staff, personnel, workforce trainings) and infrastructure (e.g., clinical system, procedures/workflows) to support rapid start implementation, but have not yet been able to, with the goal of replicating and expanding successful rapid start models. The funding will support sites in leveraging their existing staffing and clinical infrastructure to launch and implement rapid start interventions with the goal of improving engagement in care, including accelerating the period of time from new HIV diagnosis to entry into care, increasing faster linkage and re-engagement into care for those out of care, and achieving and sustaining viral suppression. The main objective of this initiative is to improve the timeliness and rates of access, linkage, and retention to HIV care, and viral suppression through the implementation of rapid start interventions for individuals newly diagnosed and aware of their HIV status, and people with HIV not currently engaged in HIV care. In addition to the implementation of rapid start interventions, a main goal of this initiative is to evaluate the effectiveness of rapid start models in improvements in early engagement, retention in care and sustained viral suppression in the RWHAP. Finally, this initiative will facilitate technical assistance (TA) to increase the capacity of health care organizations to implement rapid start interventions and provide high quality, comprehensive care and treatment in the RWHAP setting for people with HIV, especially for racial/ethnic minorities living in areas with the highest HIV burden. All implementation sites funded under this announcement will be required to collaborate with an evaluation and technical assistance provider (ETAP) (to be funded separately under HRSA-20-113) who will lead a multi-site evaluation to measure the effectiveness of rapid start models and impact in the RWHAP, and provide and facilitate TA through different venues including peer-to-peer learning. Award recipients under both NOFOs (HRSA-20-113 and HRSA-20-114) will need to work together to be successful. Therefore, HRSA encourages you to read the companion announcement and be familiar with all program expectations within both NOFOs. It is anticipated that through implementation and scale-up of rapid start interventions, earlier viral suppression rates will increase and could thereby make an impact to help reduce new HIV infections within the areas of highest HIV burden, especially among low income and racial/ethnic minority populations.

 Legislative Information

Further Consolidated Appropriations Act, 2020 (P.L. 116-94), Division A, Title II and 42 U.S.C. § 300ff-101 (section 2691 of the Public Health Service Act).

 Application Information

Application Available 04/15/2020
Application Deadline 06/15/2020
Supplemental Application Deadline N/A
Explanation for Deadline N/A
Archive Date 08/14/2020
Letter of Intent Not required
Application Package SF424
FOA Available Yes
Competitive Application Types Supported New
Allow Electronic Submission N/A
Page Limit for Application
Allow Multiple Applications
from an Organization from
Electronic Submission Instruction Electronic submission is/will be available in Grants.Gov

 General Information

Projected Award Date N/A
Estimated Project Period N/A
Estimated Project Start Date 09/01/2020
Estimated Project End Date 08/31/2023
Estimated Amount of this Competition $3,075,000.00
Estimated Number of Awards 10
Estimated Average Size of Awards $0.00
Cost Sharing No
Cooperative Agreement No

 Contact Information

Name Adan Cajina
Phone Number 301-443-3180

 Download Information

Expand FOA (Guidance) Attachment (Maximum 1)
Document Name Size Date Attached Description
HAB HRSA-20-114 (H97) final_mod.pdf 480 kB 05/15/2020
Expand Application Package (Maximum 1)
No documents attached
Expand User Guide (Maximum 1)
No documents attached

Scroll to top